{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:00:47Z","timestamp":1774497647244,"version":"3.50.1"},"reference-count":32,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To identify novel autoantibodies in acquired aplastic anemia (AA), we screened the sera of patients with AA possessing small populations of paroxysmal nocturnal hemoglobinuria (PNH)\u2013type cells for the presence of antibodies (Abs) which recognize proteins derived from a leukemia cell line, UT-7. Immunoblotting using proteins derived from lysates or culture supernatants of UT-7 cells revealed the presence of IgG Abs specific to an 80-kDa protein. Peptide mass fingerprinting identified this 80-kDa protein as moesin. Enzyme-linked immunosorbent assay (ELISA) using recombinant moesin showed high titers of antimoesin Abs in 25 (37%) of 67 patients with AA. Moesin was secreted from several myeloid leukemia cell lines other than UT-7, such as OUN-1 and K562, as an exosomal protein. The presence of antimoesin Abs was significantly correlated with the presence of PNH-type cells and antidiazepam-binding inhibitor-related protein-1 (DRS-1) Abs. Patients with AA that did not show any of these 3 markers tended to respond poorly to immunosuppressive therapy. These findings suggest that a B-cell response to moesin, possibly derived from hematopoietic cells, frequently occurs in patients with AA and that detection of antimoesin Abs in combination with other markers may be useful in diagnosing immune pathophysiology in patients with AA.<\/jats:p>","DOI":"10.1182\/blood-2006-07-036715","type":"journal-article","created":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T01:31:22Z","timestamp":1163727082000},"page":"2514-2520","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia"],"prefix":"10.1182","volume":"109","author":[{"given":"Hiroyuki","family":"Takamatsu","sequence":"first","affiliation":[{"name":"Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingmin","family":"Feng","sequence":"additional","affiliation":[{"name":"Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Chuhjo","sequence":"additional","affiliation":[{"name":"Internal Medicine, NTT West Kanazawa Hospital, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuzhang","family":"Lu","sequence":"additional","affiliation":[{"name":"Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Sugimori","sequence":"additional","affiliation":[{"name":"Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Okawa","sequence":"additional","affiliation":[{"name":"Biomolecular Characterization Unit, Frontier Technology Center HMRO, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Iseki","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Nakao","sequence":"additional","affiliation":[{"name":"Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"key":"2019111713083350700_B1","doi-asserted-by":"crossref","unstructured":"Viale M, Merli A, Bacigalupo A. Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood1991; 78:1268\u20131274.","DOI":"10.1182\/blood.V78.5.1268.1268"},{"key":"2019111713083350700_B2","doi-asserted-by":"crossref","unstructured":"Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med1985; 312:257\u2013265.","DOI":"10.1056\/NEJM198501313120501"},{"key":"2019111713083350700_B3","doi-asserted-by":"crossref","unstructured":"Herrmann F, Griffin JD, Meuer SG, Meyer zum Buschenfelde KH. Establishment of an interleukin 2-dependent T cell line derived from a patient with severe aplastic anemia, which inhibits in vitro hematopoiesis. J Immunol1986; 136:1629\u20131634.","DOI":"10.4049\/jimmunol.136.5.1629"},{"key":"2019111713083350700_B4","doi-asserted-by":"crossref","unstructured":"Bacigalupo A, Broccia G, Corda G, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood1995; 85:1348\u20131353.","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348"},{"key":"2019111713083350700_B5","doi-asserted-by":"crossref","unstructured":"Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood1995; 85:3058\u20133065.","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058"},{"key":"2019111713083350700_B6","doi-asserted-by":"crossref","unstructured":"Wang H, Chuhjo T, Yamazaki H, et al. Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis. Eur J Haematol2001; 66:200\u2013205.","DOI":"10.1034\/j.1600-0609.2001.00376.x"},{"key":"2019111713083350700_B7","doi-asserted-by":"crossref","unstructured":"Wang H, Chuhjo T, Yasue S, Omine M, Nakao S. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood2002; 100:3897\u20133902.","DOI":"10.1182\/blood-2002-03-0799"},{"key":"2019111713083350700_B8","doi-asserted-by":"crossref","unstructured":"Sugimori C, Chuhjo T, Feng X, et al. Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood2006; 107:1308\u20131314.","DOI":"10.1182\/blood-2005-06-2485"},{"key":"2019111713083350700_B9","doi-asserted-by":"crossref","unstructured":"Lieberman SM, Evans AM, Han B, et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A2003; 100:8384\u20138388.","DOI":"10.1073\/pnas.0932778100"},{"key":"2019111713083350700_B10","doi-asserted-by":"crossref","unstructured":"Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest2002; 109:895\u2013903.","DOI":"10.1172\/JCI200214114"},{"key":"2019111713083350700_B11","doi-asserted-by":"crossref","unstructured":"Gran B and Rostami A. T cells, cytokines, and autoantigens in multiple sclerosis. Curr Neurol Neurosci Rep2001; 1:263\u2013270.","DOI":"10.1007\/s11910-001-0029-3"},{"key":"2019111713083350700_B12","doi-asserted-by":"crossref","unstructured":"Markovic-Plese S and McFarland HF. Immunopathogenesis of the multiple sclerosis lesion. Curr Neurol Neurosci Rep2001; 1:257\u2013262.","DOI":"10.1007\/s11910-001-0028-4"},{"key":"2019111713083350700_B13","doi-asserted-by":"crossref","unstructured":"Feng X, Chuhjo T, Sugimori C, et al. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood2004; 104:2425\u20132431.","DOI":"10.1182\/blood-2004-05-1839"},{"key":"2019111713083350700_B14","doi-asserted-by":"crossref","unstructured":"Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med2003; 349:139\u2013145.","DOI":"10.1056\/NEJMoa022328"},{"key":"2019111713083350700_B15","doi-asserted-by":"crossref","unstructured":"Ronkainen MS, Harkonen T, Perheentupa J, Knip M. Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and\/or type 1 diabetes. Eur J Endocrinol2005; 153:901\u2013906.","DOI":"10.1530\/eje.1.02026"},{"key":"2019111713083350700_B16","doi-asserted-by":"crossref","unstructured":"Gardas A, Blottner A, Domek H. Comparison of autoantibodies level in thyroid autoimmune diseases estimated by different methods. Exp Clin Endocrinol1988; 92:77\u201384.","DOI":"10.1055\/s-0029-1210784"},{"key":"2019111713083350700_B17","doi-asserted-by":"crossref","unstructured":"Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood1976; 48:63\u201370.","DOI":"10.1182\/blood.V48.1.63.bloodjournal48163"},{"key":"2019111713083350700_B18","doi-asserted-by":"crossref","unstructured":"Jensen ON, Podtelejnikov A, Mann M. Delayed extraction improves specificity in database searches by matrix-assisted laser desorption\/ionization peptide maps. Rapid Commun Mass Spectrom1996; 10:1371\u20131378.","DOI":"10.1002\/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.3.CO;2-X"},{"key":"2019111713083350700_B19","doi-asserted-by":"crossref","unstructured":"Hegmans JP, Bard MP, Hemmes A, et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol2004; 164:1807\u20131815.","DOI":"10.1016\/S0002-9440(10)63739-X"},{"key":"2019111713083350700_B20","doi-asserted-by":"crossref","unstructured":"Camitta BM. What is the definition of cure for aplastic anemia? Acta Haematol2000; 103:16\u201318.","DOI":"10.1159\/000040999"},{"key":"2019111713083350700_B21","doi-asserted-by":"crossref","unstructured":"Savina A, Furlan M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem2003; 278:20083\u201320090.","DOI":"10.1074\/jbc.M301642200"},{"key":"2019111713083350700_B22","doi-asserted-by":"crossref","unstructured":"de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M. Lipid raft-associated protein sorting in exosomes. Blood2003; 102:4336\u20134344.","DOI":"10.1182\/blood-2003-03-0871"},{"key":"2019111713083350700_B23","doi-asserted-by":"crossref","unstructured":"Wagatsuma M, Kimura M, Suzuki R, Takeuchi F, Matsuta K, Watanabe H. Ezrin, radixin and moesin are possible auto-immune antigens in rheumatoid arthritis. Mol Immunol1996; 33:1171\u20131176.","DOI":"10.1016\/S0161-5890(96)00083-1"},{"key":"2019111713083350700_B24","doi-asserted-by":"crossref","unstructured":"Wubbolts R, Leckie RS, Veenhuizen PT, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem2003; 278:10963\u201310972.","DOI":"10.1074\/jbc.M207550200"},{"key":"2019111713083350700_B25","doi-asserted-by":"crossref","unstructured":"Tsukita S and Yonemura S. Cortical actin organization: lessons from ERM (ezrin\/radixin\/moesin) proteins. J Biol Chem1999; 274:34507\u201334510.","DOI":"10.1074\/jbc.274.49.34507"},{"key":"2019111713083350700_B26","doi-asserted-by":"crossref","unstructured":"Masumoto J, Sagara J, Hayama M, Hidaka E, Katsuyama T, Taniguchi S. Differential expression of moesin in cells of hematopoietic lineage and lymphatic systems. Histochem Cell Biol1998; 110:33\u201341.","DOI":"10.1007\/s004180050262"},{"key":"2019111713083350700_B27","unstructured":"Schwartz-Albiez R, Merling A, Spring H, Moller P, Koretz K. Differential expression of the microspike-associated protein moesin in human tissues. Eur J Cell Biol1995; 67:189\u2013198."},{"key":"2019111713083350700_B28","unstructured":"Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. 1991;New York, NY Oxford University Press."},{"key":"2019111713083350700_B29","doi-asserted-by":"crossref","unstructured":"Hirano N, Butler MO, Von Bergwelt-Baildon MS, et al. Autoantibodies frequently detected in patients with aplastic anemia. Blood2003; 102:4567\u20134575.","DOI":"10.1182\/blood-2002-11-3409"},{"key":"2019111713083350700_B30","doi-asserted-by":"crossref","unstructured":"Hirano N, Butler MO, Guinan EC, Nadler LM, Kojima S. Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients. Br J Haematol2005; 128:221\u2013223.","DOI":"10.1111\/j.1365-2141.2004.05317.x"},{"key":"2019111713083350700_B31","doi-asserted-by":"crossref","unstructured":"Chaput N, Taieb J, Schartz NE, Andre F, Angevin E, Zitvogel L. Exosome-based immunotherapy. Cancer Immunol Immunother2004; 53:234\u2013239.","DOI":"10.1007\/s00262-003-0472-x"},{"key":"2019111713083350700_B32","doi-asserted-by":"crossref","unstructured":"Delcayre A, Shu H, Le Pecq JB. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway. Expert Rev Anticancer Ther2005; 5:537\u2013547.","DOI":"10.1586\/14737140.5.3.537"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/6\/2514\/1477895\/zh800607002514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/6\/2514\/1477895\/zh800607002514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T18:59:17Z","timestamp":1683658757000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/6\/2514\/23307\/Specific-antibodies-to-moesin-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,11,16]]},"published-print":{"date-parts":[[2007,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-07-036715","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,16]]}}}